热门资讯> 正文

Aytu BioPharma SEARCH 4 2025年盈利预览

2025-09-23 05:35

Aytu BioPharma (NASDAQ:AYTU) is scheduled to announce FQ4 earnings results on Tuesday, September 23rd, after market close.
The consensus EPS Estimate is -$0.06 and the consensus Revenue Estimate is $17.92M.

More on Aytu BioPharma

FDA targets drug marketing, advertising with slew of warning letters
Seeking Alpha’s Quant Rating on Aytu BioPharma
Historical earnings data for Aytu BioPharma
Financial information for Aytu BioPharma

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。